NASDAQ
Cognition Therapeutics, Inc. (CGTX) has a free cash flow growth of -61.25% as of Friday, May 29, 2026. This represents a 483.21% decrease compared to its 12-month average of 15.98%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.